Litcius/Paper detail

Measuring school level attributable risk to support school-based HPV vaccination programs

Cassandra Vujovich‐Dunn, Handan Wand, Julia Brotherton, Heather F. Gidding, Jana Sisnowski, R. Lorch, Mark Veitch, Vicky Sheppeard, Paul V. Effler, S. Rachel Skinner, Alison Venn, Cristyn Davies, Jane S. Hocking, Lisa J Whop, Julie Leask, Karen Canfell, Lena Sanci, Megan A. Smith, Melissa Kang, Meredith Temple‐Smith, Michael Kidd, Sharyn Burns, Linda Selvey, Dennis Meijer, S. Ennis, Chloe Thomson, N. Lane, John Kaldor, Rebecca Guy

2022BMC Public Health23 citationsDOIOpen Access PDF

Abstract

BACKGROUND: In Australia in 2017, 89% of 15-year-old females and 86% of 15-year-old males had received at least one dose of the HPV vaccine. However, considerable variation in HPV vaccination initiation (dose one) across schools remains. It is important to understand the school-level characteristics most strongly associated with low initiation and their contribution to the overall between-school variation. METHODS: A population-based ecological analysis was conducted using school-level data for 2016 on all adolescent students eligible for HPV vaccination in three Australian jurisdictions. We conducted logistic regression to determine school-level factors associated with lower HPV vaccination initiation (< 75% dose 1 uptake) and estimated the population attributable risk (PAR) and the proportion of schools with the factor (school-level prevalence). RESULTS: The factors most strongly associated with lower initiation, and their prevalence were; small schools (OR = 9.3, 95%CI = 6.1-14.1; 33% of schools), special education schools (OR = 5.6,95%CI = 3.7-8.5; 8% of schools), higher Indigenous enrolments (OR = 2.7,95% CI:1.9-3.7; 31% of schools), lower attendance rates (OR = 2.6,95%CI = 1.7-3.7; 35% of schools), remote location (OR = 2.6,95%CI = 1.6-4.3; 6% of schools,) and lower socioeconomic area (OR = 1.8,95% CI = 1.3-2.5; 33% of schools). The highest PARs were small schools (PAR = 79%, 95%CI:76-82), higher Indigenous enrolments (PAR = 38%, 95%CI: 31-44) and lower attendance rate (PAR = 37%, 95%CI: 29-46). CONCLUSION: This analysis suggests that initiatives to support schools that are smaller, with a higher proportion of Indigenous adolescents and lower attendance rates may contribute most to reducing the variation of HPV vaccination uptake observed at a school-level in these jurisdictions. Estimating population-level coverage at the school-level is useful to guide policy and prioritise resourcing to support school-based vaccination programs.

Topics & Concepts

MedicineBiostatisticsDemographyAttendanceVaccinationLogistic regressionEpidemiologyPopulationAttributable riskSocioeconomic statusEnvironmental healthImmunologyInternal medicineEconomic growthEconomicsSociologyCervical Cancer and HPV ResearchVaccine Coverage and HesitancyWomen's cancer prevention and management
Measuring school level attributable risk to support school-based HPV vaccination programs | Litcius